human
bocaviru
recent
describ
novel
member
parvovirida
infect
human
base
accumul
clinic
epidemiolog
data
viru
current
associ
respiratori
infect
young
children
infant
furthermor
discuss
caus
agent
gastrointestin
ill
acut
respiratori
tract
infect
arti
caus
virus
repres
major
caus
hospit
morbid
young
children
infant
worldwid
pathogen
associ
clinic
condit
includ
respiratori
syncyti
viru
rsv
human
adenoviru
human
metapneumoviru
coronavirus
although
constantli
grow
number
pathogen
associ
arti
high
percentag
infect
still
remain
uncharacter
caus
agent
unknown
alland
et
al
describ
previous
uncharacter
viru
pool
human
nasopharyng
aspir
obtain
children
suffer
diseas
respiratori
tract
comprehens
sequenc
phylogenet
analys
reveal
close
relat
new
viru
bovin
parvoviru
bpv
canin
minut
viru
cnmv
member
bocaviru
genu
parvovirida
famili
therefor
provision
name
human
bocaviru
hbov
parvovirus
repres
larg
famili
small
nonenvelop
virus
character
linear
singlestrand
dnagenom
except
structur
simplic
besid
hbov
two
addit
parvovirus
parvoviru
includ
second
genotyp
term
current
known
discuss
infect
human
almost
three
decad
repres
member
viru
famili
caus
ill
human
eg
selflimit
childhood
diseas
erythema
infectiosum
addit
infect
pregnanc
known
frequent
result
intrauterin
infect
fetu
occasion
lead
miscarriag
hydrop
fetali
clinic
relev
remain
unclear
date
evid
influenc
hbov
infect
manifest
respiratori
gastric
symptom
accumul
detect
hbov
igg
igm
ng
purifi
hbov
viruslik
particl
gener
previous
describ
coat
onto
nuncimmuno
tm
medisorp
tm
plate
nunc
gmbh
wiesbaden
germani
coat
buffer
na
co
nahco
ph
overnight
c
plate
subsequ
wash
six
time
wash
buffer
pb
tween
block
dilut
buffer
pb
tween
fc
h
c
incub
respect
serum
sampl
h
c
plate
wash
rabbit
antihuman
iggor
igmspecif
hrpcoupl
secondari
antibodi
ad
h
c
dilut
buffer
respect
dako
deutschland
gmbh
hamburg
germani
develop
perform
use
bd
opteia
tm
substrat
bd
bioscienc
heidelberg
germani
accord
manufactur
instruct
intern
igg
standard
hbov
yet
avail
serial
dilut
sera
healthi
adult
male
age
year
boy
age
month
exhibit
strong
hbovspecif
iggand
igmrespons
respect
introduc
intern
refer
use
calcul
hbovspecif
antibodi
titer
perform
experi
sera
background
optic
densiti
consid
neg
use
determin
respect
iggigm
cutoff
valu
addit
confirm
western
blot
analysi
report
list
pubmeddatabas
nation
librari
medicin
rockvil
pike
md
usa
may
consid
evalu
review
date
cell
cultur
system
vitro
replic
hbov
describ
therefor
diagnosi
hbov
infect
far
mainli
base
detect
viral
genom
present
human
respiratori
serum
stool
urin
sampl
use
differ
pcr
techniqu
employ
numer
set
primer
specif
viral
gene
recent
report
describ
detect
hbovspecif
antibodi
direct
viral
capsid
protein
andor
serum
sampl
use
elisa
western
blot
immunofluoresc
assay
date
crossreact
hbovand
humor
andor
cellular
immun
respons
describ
hbovdna
frequent
detect
worldwid
respiratori
serum
fecal
urin
sampl
obtain
infant
mainli
around
year
age
preval
hbovdna
describ
vari
consider
children
suffer
arti
patient
gastroenter
howev
sinc
major
current
publish
studi
perform
retrospect
variat
viral
preval
may
explain
differ
studi
popul
patient
characterist
infect
infant
viral
load
describ
rang
genom
copi
nasopharyng
aspir
fecal
sampl
respect
serum
detect
viral
load
ml
limit
data
avail
preval
hbov
viremia
asymptomat
individu
sinc
studi
focus
children
distinct
clinic
symptom
infecti
diseas
first
studi
total
healthi
control
includ
diagnost
analysi
hbov
yet
viral
dna
observ
respiratori
sampl
individu
furthermor
unabl
detect
hbovdna
sera
collect
healthi
adult
blood
donor
howev
recent
public
describ
detect
viral
genom
respiratori
sampl
obtain
asymptomat
children
studi
detect
viru
winter
season
singl
report
describ
increas
number
viral
infect
spring
summer
inform
current
avail
rout
viral
transmiss
howev
sinc
hbov
frequent
detect
respiratori
fecal
sampl
transmiss
viru
via
aerosol
direct
contact
presum
therebi
contagi
viruscontain
bodi
secret
might
potenti
except
stabil
parvovir
virion
might
facilit
increas
frequenc
nosocomi
infect
date
limit
number
studi
focus
analysi
hbovspecif
adapt
immun
respons
healthi
individu
infant
suffer
arti
mainli
due
initi
lack
recombin
viral
antigen
standard
diagnost
methodolog
first
report
publish
hbov
seropreval
endo
cowork
describ
ubiquit
iggrespons
viral
capsid
protein
children
age
year
respiratori
infect
overal
seropreval
hbovspecif
igg
japanes
popul
age
month
year
seroneg
patient
observ
frequent
infant
month
age
subsequ
studi
preval
hbovspecif
antibodi
finnish
infant
suffer
arti
assess
use
western
blot
children
determin
posit
hbovdna
iggand
igmantibodi
viral
protein
observ
analyz
sampl
respect
mean
age
children
year
overal
preval
hbovspecif
igg
igm
children
without
detect
viral
genom
nasopharyng
sampl
respect
antibodi
aminotermin
domain
viral
protein
term
region
detect
rare
igg
igm
patient
show
posit
result
contrast
data
provid
endo
colleagu
group
see
preval
hbovspecif
igg
shown
declin
year
old
infant
children
age
year
finnish
studi
furthermor
matern
igg
observ
children
month
age
despit
seemingli
high
seropreval
hbov
adult
find
may
due
matur
iggspecif
time
period
month
follow
acut
infect
antibodi
linear
epitop
get
replac
preferenti
recogn
conform
antigen
structur
process
well
document
humor
immun
respons
therefor
may
assum
similar
chang
igg
affin
take
place
hbov
infect
recent
other
establish
elisa
assay
base
use
recombin
hbov
detect
hbovspecif
antibodi
human
serum
sampl
herein
group
observ
preval
igg
subclass
antibodi
hbov
rise
children
month
age
adult
blood
donor
mean
age
year
addit
humor
immun
reaction
presenc
hbovspecif
tcell
healthi
adult
support
high
preval
hbovspecif
immun
adult
therebi
frequent
interferongamma
ifn
mediat
helper
cell
reaction
observ
hbov
capsid
protein
similar
data
previous
describ
cellular
immun
respons
hbov
infect
frequent
link
high
rate
coinfect
viral
bacteri
pathogen
respiratori
andor
gastrointestin
system
togeth
fact
studi
perform
retrospect
longterm
followup
studi
detail
clinic
character
symptomat
individu
rare
current
difficult
clearli
determin
hbov
sole
infecti
agent
human
ill
date
hbov
infect
detect
young
children
around
age
year
acut
diseas
upper
lower
respiratori
tract
frequent
combin
interstiti
lung
infiltr
abnorm
radiolog
find
hbov
posit
individu
detect
virusspecif
igg
igm
studi
sera
wherea
igm
observ
sampl
obtain
children
without
detect
amount
hbov
genom
blood
symptom
diseas
manifest
observ
hbov
infect
children
includ
pneumonia
bronchiol
wheez
respiratori
distress
hypoxia
fever
rhiniti
laryng
croup
rare
conjunct
rash
adult
acut
hbov
infect
lead
arti
seem
rare
current
detect
mainli
immunocompromis
singl
immunocompet
individu
recent
presenc
elev
viral
load
nasopharyng
aspir
genom
copiesml
suggest
correl
sever
respiratori
symptom
hbov
infect
wherea
low
viral
load
genom
copiesml
may
repres
viral
persist
data
contrast
publish
klein
et
al
could
find
relat
viral
load
sever
hbov
associ
ill
indic
work
necessari
studi
influenc
viral
load
respiratori
diseas
manifest
howev
infect
relat
parvoviru
often
result
prolong
replic
viru
infect
individu
therefor
mechan
persist
may
also
appli
hbov
individu
found
posit
hbovdna
nasopharyng
aspir
frequent
found
coinfect
multitud
addit
viral
andor
bacteri
respiratori
pathogen
therebi
high
rate
coinfect
reach
observ
commonli
detect
addit
pathogen
includ
rsv
human
adenoviru
rhinoviru
streptococcu
sp
despit
high
rate
coinfect
hbov
viremia
frequent
describ
significantli
preval
infant
suffer
arti
agematch
asymptomat
control
group
therefor
role
hbov
develop
human
respiratori
diseas
presum
find
support
data
show
significantli
higher
preval
hbov
infect
young
children
lower
respiratori
tract
infect
compar
control
group
agematch
individu
hospit
due
noninfecti
condit
bone
fractur
plan
surgeri
addit
respiratori
symptom
hbov
current
discuss
associ
gastroenterit
symptom
similar
featur
known
veterinari
infect
close
relat
bpv
cnmv
known
induc
gastric
ill
respect
host
first
report
describ
preval
hbov
genom
rang
fecal
sampl
obtain
children
suffer
acut
gastroenter
often
combin
arti
recent
prospect
studi
detect
hbovdna
fecal
sampl
obtain
young
children
exhibit
gastrointestin
symptom
eg
diarrhea
nausea
vomit
addit
child
test
posit
hbov
diagnos
inflammatori
bowel
diseas
coinfect
intestin
pathogen
eg
human
rotaand
norovirus
enteropathogen
strain
escherichia
coli
salmonella
sp
frequent
observ
hbov
posit
individu
associ
hbov
gastroenter
remain
unclear
sinc
mani
case
hbovdna
detect
concurr
stool
sampl
nasopharyng
aspir
obtain
young
children
arti
presenc
hbov
fecal
sampl
might
repres
natur
viral
shed
acut
hbov
infect
play
activ
role
pathogenesi
gastric
diseas
although
hbov
detect
three
year
ago
epidemiolog
clinic
data
establish
viru
second
member
parvovirida
pathogen
human
accumul
base
current
report
seem
like
hbov
may
associ
respiratori
infect
young
children
infant
connect
hbov
gastrointestin
symptom
suggest
howev
acut
hbov
infect
often
accompani
infect
addit
pathogen
respiratori
gastrointestin
tract
final
establish
hbov
caus
agent
infecti
diseas
human
need
confirm
addit
prospect
studi
methodolog
heterogen
use
diagnosi
hbov
infect
rais
question
specif
compar
mani
publish
studi
highlight
urgent
need
intern
standard
diagnost
guidelin
refer
sampl
detect
hbov
genom
virusspecif
immun
respons
human
sampl
serolog
diagnost
hbov
infect
becom
import
futur
standard
viral
dna
antibodi
specimen
provid
basi
establish
compar
test
system
nevertheless
first
data
obtain
healthi
control
individu
children
symptom
noninfecti
diseas
indic
distinctli
lower
rate
hbov
infect
comparison
patient
suffer
arti
whether
hbov
might
requir
presenc
helpervirus
establish
human
ill
may
even
act
provid
cofactor
respiratori
virus
remain
assess
studi
